This bill would revoke the tax-exempt status of nonprofit organizations (like charities or health groups) that provide or fund abortions, except in specific cases. It directly affects organizations currently classified under Section 501(c)(3) of the tax code, such as some healthcare providers or advocacy groups. Key provisions define "abortion" as intentionally terminating a pregnancy (excluding cases where the mother’s life is at risk, or the pregnancy resulted from rape or incest), and deny tax exemption to groups meeting this definition. The change would take effect for tax years starting after the bill’s enactment date.
HR 685, the SAVE Moms and Babies Act of 2025, prohibits the FDA from approving new abortion drugs or allowing investigational use of existing ones. It restricts existing abortion drugs to in-person administration by certified healthcare providers in clinics or hospitals (not pharmacies), limits use to pregnancies under 70 days gestation, and requires providers to certify they can handle complications like severe bleeding or ectopic pregnancies. The bill mandates reporting of adverse events (such as hospitalizations or infections) to the FDA without patient identifiers and defines "abortion drug" broadly as any drug intended to terminate pregnancy, excluding specific medical exceptions. This directly affects FDA approval processes, healthcare providers prescribing these drugs, and drug manufacturers.
The PLASMA Act (S 694) modifies Medicare Part D drug discount rules for plasma-derived products - biological drugs made from human blood plasma. It establishes a phased reduction in the discount rate these drugs must offer to Medicare beneficiaries, starting at 99% of the negotiated price in 2026 and gradually decreasing to 80% by 2032. This affects manufacturers of plasma-derived drugs covered under Medicare Part D and beneficiaries who meet specific out-of-pocket cost thresholds. The bill excludes certain low-income beneficiaries and small manufacturers from these provisions. The policy change directly alters how drug costs are calculated for these specific medications under Medicare.
HR 7213, the *Safeguarding Benefits for Americans Act of 2026*, requires U.S. citizenship or nationality for eligibility for most federal assistance programs (like SNAP, housing aid, or Medicaid). It mandates applicants to submit a written declaration under penalty of perjury and provide documentary proof (e.g., birth certificate, SSN) verified through Social Security Administration and DHS databases. The bill affects individuals applying for or receiving federal benefits, with exceptions for children in households where at least one member meets the requirement (e.g., children in SNAP or elderly housing programs). It takes effect 1 year after enactment, requiring all current recipients to meet the new rules within 2 years.
HR 272, the Protecting Life and Taxpayers Act of 2025, prohibits federal funding (directly or indirectly) to any organization that performs or funds abortions, requiring certification from all recipients. This applies to entities receiving federal funds, including contractors and subsidiaries, with limited exceptions for pregnancies resulting from rape or incest, or when a physician certifies a life-threatening condition. The bill directly affects healthcare providers, clinics, and organizations that rely on federal grants or contracts. It changes existing funding rules by banning federal money from supporting abortion services, except in the specified medical or criminal exceptions.
HR 6876, the "Protecting Children from Foreign Mutilation Act," imposes visa bans on foreign medical professionals or facilities that provide certain gender-affirming treatments to U.S. minors under 18. It targets foreign physicians or clinics performing "chemical or surgical mutilations" (defined as puberty blockers, hormones, or surgeries altering physical sex characteristics for transgender youth), excluding medically necessary care for intersex conditions or injuries. The bill requires the President to revoke visas for qualifying foreign providers and mandates a report to Congress on enforcement within 180 days. It explicitly excludes detransition treatments and medically necessary care for conditions like intersex variations or trauma. The law applies solely to foreign providers, not U.S. healthcare.
The Defending American Sovereignty in Global Pandemics Act requires Senate approval before the U.S. can join any international pandemic agreement under the World Health Organization (WHO). It would suspend all U.S. funding to the WHO until the Senate ratifies such an agreement. This policy directly affects U.S. financial support to the WHO and the process for international health cooperation. The funding freeze would begin immediately and continue until the Senate approves the specific treaty.
The America First Act would restrict eligibility for numerous federal benefit programs based on immigration status. It requires verification of citizenship or lawful immigration status for programs including Medicaid, Medicare, Head Start, school meals, WIC, the Child Tax Credit, Earned Income Tax Credit, and housing assistance. The bill specifically would deny benefits to individuals who are unlawfully present in the U.S. or who have certain immigration statuses including parolees, Temporary Protected Status (TPS) recipients, DACA recipients, and asylum seekers. These provisions would directly affect millions of immigrants and their families who currently qualify for these programs. The bill would also prohibit use of FEMA assistance for certain non-citizens and limit access to postsecondary financial aid based on immigration status.
This bill repeals a federal law (18 U.S.C. § 248) that prohibited blocking access to clinic entrances, particularly abortion clinics. It directly affects protesters who block clinic entrances and law enforcement handling such protests by removing the federal criminal penalty for this action. The key provision is the complete repeal of Section 248, meaning blocking clinic access would no longer be a federal crime under this law, applying to prosecutions starting on or after the bill's enactment date.
The Protect Medicaid Act (S 523) prohibits federal Medicaid funds from covering administrative costs for health benefits provided to unauthorized immigrants. It directly affects states that currently offer Medicaid-like benefits to noncitizens ineligible due to immigration status, requiring them to fund these administrative costs themselves. The bill amends the Social Security Act to explicitly ban such federal spending and mandates an Inspector General report detailing how states separate costs, ensure compliance, and finance these programs (e.g., via provider taxes). The report must also analyze drug pricing impacts when unauthorized immigrants receive covered medications through Medicaid or 340B programs. This is a procedural change restricting federal funding, not altering eligibility for Medicaid benefits.
